Browsing Academic by Subject "Cytochrome P450 2C19"
Now showing items 1-2 of 2
-
Economic Evaluation of CYP2C19 Genotype-Guided Antiplatelet Therapy Compared to Universal Use of Ticagrelor or Clopidogrel in Qatar
( Qatar University Press , 2020 , Poster)Background: Patients having CYP2C19 loss-of-function alleles and receiving clopidogrel are at higher risk of adverse cardiovascular outcomes. Ticagrelor is a more effective and expensive antiplatelet that is unaffected by ... -
Short- and long-term cost-effectiveness analysis of CYP2C19 genotype-guided therapy, universal clopidogrel, versus universal ticagrelor in post-percutaneous coronary intervention patients in Qatar
( Elsevier , 2021 , Article)BackgroundPatients having CYP2C19 loss-of-function alleles and receiving clopidogrel are at higher risk of adverse cardiovascular outcomes. Ticagrelor is an effective antiplatelet that is unaffected by the CYP2C19 polymorphism. ...